Title of article
Staging efficacy of breast cancer with sentinel lymphadenectomy
Author/Authors
Noguchi، Masakuni نويسنده , , Tsugawa، Koichiro نويسنده , , Bando، Etsuro نويسنده , , Miwa، Koichi نويسنده , , Yokoyama، Kunihiko نويسنده , , NakaJima، Ken-ichi نويسنده , , Michigishi، Takatoshi نويسنده , , Tonami، Nonhisa نويسنده , , Minato، Hiroshi نويسنده , , Nonomura، Akitaka نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
-220
From page
221
To page
0
Abstract
With the current trend away from affirmative action programs, it is increasingly important that universities retain the African American and Latino students that they admit. In 1988 the University of Texas at Austin (UT) established the Emerging Scholars Program (ESP) to challenge highachieving students to excel in calculus and pursue mathematics, science, or engineering (MSE) majors. The university makes a special effort to recruit African Americans, Latinos, and women, but the ESP is open to any student, regardless of race or ethnicity, who is committed to excel in calculus. We analyze the influence of calculus performance on choosing a mathematics, science, or engineering major by focusing on variations by race, ethnicity, and gender and on the role of studentsʹ participation in the ESP. Findings suggest that ESP students earn higher calculus grades than non-ESP students and are more likely to enroll in the second semester of calculus. Also, earning higher calculus grades increases the likelihood that students will choose a major in mathematics, science, or engineering. These findings suggest that to increase the number of students choosing one of these majors, administrators must seek ways to increase studentsʹ participation in calculus each semester. In addition, African Americans, Latinos, and women excel in calculus if they receive appropriate academic challenges and support.
Keywords
prognosis , breast cancer , sentinel node dissection , axillary dissection
Journal title
BREAST CANCER RESEARCH & TREATMENT
Serial Year
1999
Journal title
BREAST CANCER RESEARCH & TREATMENT
Record number
23030
Link To Document